ClexBio is a pre-clinical tissue therapeutics company with a next-generation technology platform enabling scalable, high-throughput generation of bioengineered tissues
Bioengineered tissues develop in vivo-like features that enable therapeutic functions on a clinically-relevant scale
cm-sized tissues can be manufactured at scale with next-generation CLEX™ and VivoSet™ technologies
ClexBio is busy developing its next-generation technology into a portfolio of tissue therapeutic products, providing solutions for otherwise incurable chronic diseases
